Post-Operative Management of Parkinson Patients with Deep Brain Stimulation by Niels Allert & Volker Arnd Coenen
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
  
14 
Post-Operative Management of Parkinson 
Patients with Deep Brain Stimulation 
Niels Allert1 and Volker Arnd Coenen2 
1Neurological Rehabilitation Center Godeshoehe, Bonn 
 2Stereotaxy and MR-based OR-techniques/Department of Neurosurgery,  
University of Bonn, 
Germany 
1. Introduction 
Oral medication still remains the mainstay for treating Parkinson’s disease (PD). Since the 
introduction in the late 60ies levodopa is regarded as the gold standard because of the 
best efficacy on akinesia and rigidity compared to other drugs like dopamine agonists or 
anticholinergics (Poewe et al., 2010). However, oral dopaminergic treatment of motor 
symptoms is complicated by the development of motor fluctuations and dyskinesias. 
These complications can be observed in 40 % after 5 years and 80 % after 10 years PD 
duration. Moreover, tremor can be refractory to oral medication. During the past 15 years 
deep brain stimulation (DBS) has become an important therapeutic option for patients 
with these motor complications. DBS has been approved in Europe for the treatment of 
tremor in 1995 and for advanced PD in 1998. Approval by the Food and Drug 
Administration (FDA) was given for tremor in 1997 and for advanced PD in 2002. The 
main targets for DBS are the subthalamic nucleus (STN), the internal globus pallidus (GPi) 
and the ventral intermediate (Vim) thalamic nucleus. DBS is a symptomatic treatment and 
does not influence the progression of the disease (Hilker et al., 2005). Therefore, the 
number of patients eligible for DBS is limited. Experts estimate that some 10 to 15 % of PD 
patients are suitable candidates. The implantation of stimulation electrodes is not 
therapeutic in itself. Apart from the precise electrode localization the subsequent 
programming of optimal stimulation parameters and adjustment of medication is 
mandatory (Deuschl et al., 2006). An increasing number of PD patients are treated by DBS 
so that more and more doctors and care givers involved in the treatment of PD patients 
are regularly concerned with the special demands of these patients. The following chapter 
gives an overview on specific issues in the post-operative management of PD patients 
with DBS. 
2. Post-operative management of PD patients with DBS 
One of the reasons for the resurgence of surgical therapies in the treatment of PD is that 
DBS surgery is associated with a limited risk of permanent morbidity of 1 % (Voges et al., 
2007). Furthermore, DBS is adjustable and reversible concerning efficacy as well as side 
effects. This is in contrast to earlier neurosurgical techniques which used permanent 
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lesions of the GPi (pallidotomy) or Vim (thalamotomy). The implantation of electrodes 
alone does not result in a permanent clinical benefit but requires optimal programming of 
stimulation parameters and adjustment of medication. However, the surgical procedure 
often results in a transient microlesion effect already mimicking some of the benefits of 
chronic DBS (Mann et al., 2009). This microlesion effect implies that motor symptoms like 
tremor or akinesia are improved immediately after surgery although DBS has not been 
started. A microlesion effect is usually observed for a couple of days but can last even 
longer up to weeks. A significant microlesion effect can make the evaluation of 
stimulation effects on motor symptoms difficult. Therefore, some DBS centers routinely 
release patients after electrode implantation and admit them a couple of weeks later to 
start DBS programming. In other centers, DBS programming is started shortly after 
electrode implantation. 
2.1 Surgical issues – Follow-up of wound healing and proper technical function 
Proper technical function of the DBS system should be ascertained after surgery. Most 
notably, the impedances of all stimulation contacts of the commonly used quadripolar 
stimulation electrodes should be checked. A disconnection of a single or more electrode 
contacts is characterized by high impedances (depending on the impulse generator model 
measurements of >2.000 Ohm, >4.000 Ohm or >40.000 Ohm) when measured in a 
monopolar stimulation mode with the respective contact as cathode and the impulse 
generator case as anode. Moreover, in this case increasing the voltage will not result in 
stimulation effects of the central nervous system and will not increase the baseline current 
of the impulse generator. A short circuit on the other hand is characterized by very low 
impedances (< 100 Ohm) of the respective contacts when measured in a bipolar 
stimulation mode with one contact as cathode and the other contact as anode. Detecting a 
disconnection of single contacts or a short circuit does not necessarily imply a surgical 
revision. If stimulation of alternative contacts is effective and satisfying the dysfunction 
should only be regularly controlled in the course of time to exclude extension of technical 
problems to other leads. In contrast, complete fractures of electrodes or extension leads 
necessitate surgical revision. Lead fractures have been reported in up to 5 % of the 
patients in earlier reports (Hamani & Lozano, 2006). In most of these cases the connection 
between stimulation electrode and extension lead was located below the mastoid. This 
risk can be significantly reduced if the connection is located at the calvarium (Blomstedt & 
Hariz, 2005).  
Wound healing should be carefully controlled during the first weeks after surgery but also 
at control visits thereafter. A sterile seroma can occur around the impulse generator but 
resolves spontaneously in most cases. However, bacterial infections can develop requiring 
surgical and antibiotic treatment. Bacterial infections are most often found at the impulse 
generator site within 4 to 6 weeks after implantation but can also occur at other parts of the 
DBS system (extension lead, electrode). They are exceptionally rare intracranially (Sillay et 
al., 2008). In most cases of a bacterial infection at the DBS system mere antibiotic treatment 
does not eradicate bacteria completely so that the system or part of the system needs to be 
explanted and replaced after a period of consolidation (Bhatia et al., 2010). Apart from 
infections, skin erosions can be a problem (Sixel-Döring et al., 2010). Such skin erosions can 
even occur after months and need surgical revision to prevent secondary bacterial infection 
(Lanotte et al., 2009). 
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2.2 Determination of optimal stimulation parameters 
DBS for PD is a chronic high frequency stimulation of central nervous tissue without 
feedback mechanisms like the sensing of intrinsic electric activity by cardiac pacemakers.  
Telemetric programming allows adjusting the stimulation frequency (in Hz), the impulse 
width (in µs) and the stimulation amplitude (in V in case of constant voltage stimulation and 
in µA in case of constant current stimulation). Furthermore, quadripolar stimulation 
electrodes allow variable activation of single or more electrode contacts for either 
monopolar DBS with the impulse generator serving as anode or bipolar DBS with anode 
and cathode both being located at the electrode. The principle of DBS programming in PD is 
to systematically evaluate the clinical responses to stimulation in order to obtain maximal 
benefit on motor symptoms without or with minimized side effects. This process has to 
encounter variable latencies of stimulation effects at the different DBS targets which range 
from seconds to weeks. 
2.2.1 Subthalamic nucleus - STN 
The subthalamic nucleus has become the primary DBS target in PD during the last 10 to 15 
years (Benabid et al., 2009). The sub-target for PD motor symptoms is the dorsolateral hence 
sensorimotor STN better referred to as the anterior lateral and superior STN (Coenen et al., 
2008). The main reasons for this preference are that all PD motor symptoms including 
tremor, akinesia and rigidity are improved allowing a reduction of dopaminergic 
medication by some 60 %. The latter also results in a significant reduction of dyskinesias. 
Recent studies, however, have questioned whether GPi DBS may be equally effective or 
even superior in individual patients (Follett et al., 2010). 
STN DBS directly improves PD off symptoms. Therefore, stimulation effects are best 
evaluated in the medication off state. The influence of the different stimulation parameters 
on motor symptoms has been evaluated more systematically in several studies (e.g. Moro et 
al., 2002). Stimulation frequency has to be above 60 Hz. An increase of the frequency to more 
than 100 Hz improves DBS efficacy whereas the further benefit of frequencies above 130 Hz 
is usually limited. To prevent unnecessary current drainage a frequency of 130 Hz can be 
recommended as the preferred frequency for STN DBS. The impulse width is commonly set 
at the lowest technical option of 60 µs. Increasing the impulse width does usually not result 
in specific advantages but results in a negative relationship of DBS efficacy and current 
drainage. Activation of different contacts of the commonly used quadripolar stimulation 
electrodes allows to further modify the volume of tissue activated. Initially, efficacy of DBS 
as well as side effects is evaluated for all contacts separately to determine the contact(s) with 
the best short term efficacy within seconds to minutes.  
Rigidity has been found to be a particularly valuable symptom because of a short latency 
response. Moreover, rigidity can be reliably evaluated when using reinforcing 
manoeuvres like voluntary movements of the contralateral hand (Froment’s manoeuvre). 
Akinesia often responds within short time as well but full anti-akinetic effect of DBS may 
take hours to days. Whereas tremor in DBS of the Vim usually responds within seconds, 
variable latencies can be observed in STN DBS which range from seconds to weeks. 
Stimulation-induced dyskinesias are another important motor phenomenon to evaluate 
DBS efficacy. Stimulation-induced dyskinesias have been demonstrated to be a predictor 
of good long-term outcome of DBS (Gago et al., 2008). Most importantly, dyskinesias 
often develop or increase in severity with a latency of minutes to hours so that careful 
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observation of patients after initiation of DBS is recommended. In case of persistent 
stimulation induced dyskinesias or if the therapeutic window of sufficient symptom 
control and the induction of dyskinesias is narrow a more dorsal stimulation contact often 
offers a beneficial alternative. 
Apart from motor symptoms DBS can induce psychiatric and behavioural changes. Most of 
these changes are transient but can be observed during periods of days to weeks and even a 
couple of months (Temel et al., 2006). The origin of such changes still needs further 
exploration. Both, direct stimulation of nervous tissue involved in the processing of 
emotions as well as changes in dopaminergic medication seem to play a role. Although 
direct stimulation-induced depression has been observed in PD patients with STN DBS 
(Bejjani et al., 1999), depression seems to be more often due to the reduction of 
dopaminergic medication and can be improved by increasing this medication (Thobois et 
al., 2010). In contrast, hypomania seems to be more directly related to stimulation effects. 
Stimulation of the inferior and medial STN corresponding to the limbic subnucleus of the 
STN has been proposed as a likely structure. Our own studies also suggest the medial 
forebrain bundle as a candidate (Coenen et al., 2009). Clinically, stimulation induced 
hypomania can usually be improved by either reducing the volume of tissue activated or by 
stimulating a more dorsal contact. 
 
 
Fig. 1. Algorithm for stimulator and medication adjustments in PD patients with STN DBS 
(dotted arrows: rare) (adapted from Allert et al., 2011) 
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Due to the different latencies of stimulation effects as well as adaptive changes with chronic 
stimulation patients need to be observed and stimulation parameters as well as medication 
continuously adapted during the first days to weeks. Figure 1 depicts a clinical algorithm for 
this process of stimulator and medication adjustments. 
2.2.2 Globus pallidus internus - GPi 
Stimulation of the GPi also improves the major PD motor symptoms, i. e. tremor, akinesia 
and rigidity. However, initial studies suggested a less profound effect on akinesia 
corresponding to only little changes in dopaminergic medication. Moreover, failure of GPi 
DBS has been reported within the first years as well as after longer periods up to 10 years 
(Durif et al., 2002; Allert et al., 2010). More recent studies, in contrast, have demonstrated 
similar motor outcome after STN DBS and GPi DBS with more favourable effects on non-
motor symptoms like depression in patients with GPi DBS (Follett et al., 2010). Further 
studies are certainly needed to evaluate the differential effects of GPi DBS and STN DBS on 
motor and non-motor symptoms in PD. 
DBS of the GPi differs in some aspects from DBS of the STN. Anatomically, the sensorimotor 
area of the GPi is larger than the sensorimotor area of the subthalamic nucleus. To increase 
the volume of tissue activated higher amplitudes and impulse widths are used. 
Correspondingly, the higher energy consumption results in a shorter battery longevity of 
impulse generators. A differential effect of variable impulse widths has not been 
demonstrated. Historically, longer impulse widths were often used for pallidal stimulation 
in the 90ies, because the most common impulse generators at that time doubled energy 
consumption above amplitudes of 3.6 V so that the combination of an amplitude below 3.7 V 
and a longer impulse width resulted in improved battery longevity. Newer generations of 
impulse generators have a linear relationship of stimulation amplitude and current 
consumption so that the initial use of short impulse widths (60 µs) is justified and probably 
preferable. 
Another important difference is that GPi DBS reduces levodopa-induced dyskinesias 
directly. Hence, stimulation effects have to be evaluated in the medication on and off state 
separately. This is even more important because DBS of different parts of the GPi can have 
opposite motor effects. Thus, a more ventral target in the GPi may result in suppression of 
levodopa induced dyskinesias but increase in akinesia whereas a more dorsal target may 
even elicit dyskinesias while improving OFF akinesia (Krack et al., 1998). 
As mentioned above, changes of dopaminergic medication are less profound in GPi DBS 
than in STN DBS (Follett et al., 2010). Adjustment of medication after GPi DBS is, therefore, 
less likely to induce dopaminergic withdrawal symptoms like apathy and anhedonia and 
probably contributes to the more favorable outcome on non-motor symptoms like 
depression (Follett et al., 2010). 
2.2.3 Ventral intermediate thalamic nucleus - Vim 
Whereas in the late 80ies the ventral intermediate thalamic nucleus has been the first target for 
DBS in patients with medically refractory tremor it’s role in PD has diminished with the 
demonstration that DBS of the GPi and STN not only improves tremor but also reduces 
akinesia and rigidity. Vim DBS is very effective in reducing PD tremor but has no impact on 
akinesia and rigidity. Stimulation effects can be observed within seconds making DBS 
programming easier than that in STN and GPi DBS. Stimulation parameters are comparable to 
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those for GPi and STN DBS, i. e. a frequency of 130 Hz and short impulse widths of 60 µs can 
be recommended for initial programming. In case of unsatisfactory tremor control higher 
stimulation frequencies can be helpful although a significant benefit of higher stimulation 
frequencies for tremor suppression has not been systematically demonstrated. The most 
important side effects of Vim DBS, particularly in the case of bilateral DBS are impairment of 
speech and gait/balance. These side effects are reversible and depend on the volume of tissue 
activated. If tremor is incompletely suppressed the aim of DBS programming is to find an 
optimal compromise between tremor control and acceptable side effects. 
2.3 Adjustment of medication 
Adjustment of dopaminergic medication is primarily necessary in PD patients with STN 
DBS. A reduction of some 60 % of the levodopa equivalent dosage has been reported in a 
number of studies (Benabid et al., 2009) whereas little changes are observed in PD patients 
with GPi DBS (Follett et al., 2010; Deep brain stimulation for Parkinson’s disease study 
group, 2001). Since Vim DBS only improves tremor but not akinesia and rigidity, the 
possibility to reduce dopaminergic medication depends on the tremor control by DBS and 
prevalence of akinesia and rigidity in the individual patient. 
Adjustment of dopaminergic medication is very important in patients undergoing STN 
surgery. In most DBS centers test stimulation is used during electrode implantation to 
evaluate neurophysiologically the localization of the electrode. Patients are awake and 
examined for characteristic side effects like muscle contractions from stimulation of the 
pyramidal tract, dysaesthesias from stimulation of the medial lemniscus, oculomotor 
disorders from stimulation of the oculomotor nerve or the pyramidal tract (gaze palsy). 
Moreover, test stimulation is used to evaluate the effect on PD motor symptoms. The latter 
can best be evaluated in the medication off state so that dopaminergic medication is not 
given on the day of surgery. To prevent unforeseen long-term effects of dopamine agonists 
with a long half-life some DBS centers routinely reduce or even discontinue dopamine 
agonists for a couple of days before surgery. A reduction of dopaminergic medication may 
also be necessary immediately after electrode implantation because of a microlesion effect 
with an increase in dyskinesias. Many DBS centers favour a levodopa monotherapy during 
the first weeks of DBS programming because of the short half-life which allows better 
adjustments in response to the DBS effect. A mean reduction of 60 % of the levodopa 
equivalent dosage can be observed in STN DBS with complete withdrawal in 10 to 30 %. If 
the DBS effects consolidate and the need for further dopaminergic medication can be better 
evaluated dopamine agonists can be initiated and adjusted following the same principles as 
in PD patients without DBS. Apart from the effects on motor symptoms the effects of 
dopaminergic medication on non-motor symptoms have to be evaluated. Most notably, 
apathy and anhedonia/depression have been associated with a treatable dopaminergic 
deficit (Thobois et al., 2010; Czernecki et al., 2008). The goal of DBS and medication 
adjustment, therefore, should be optimal control of both, motor as well as non-motor 
symptoms but not a drastic reduction or even withdrawal of dopaminergic medication. 
2.4 Management of symptom deterioration 
DBS of neither target prevents further disease progression (Hilker et al., 2005). All patients 
with successful DBS therapy will experience worsening of symptoms and development of 
new symptoms during the following years. 
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In case of acute onset of symptoms a technical dysfunction of the DBS system should be 
excluded. This check should include determination of battery function and a control of the 
impedances to detect a possible lead fracture/disconnection or a short circuit. Battery failure 
or a disconnection of the active stimulation contact(s) can result in a sudden increase in PD 
motor symptoms. A short circuit, in contrast, can result in sudden spread of electrical 
current to adjacent nervous tissue like the pyramidal tract or the oculomotor nerve with 
consequent tetanic muscle contraction or eye deviation. A secondary dislocation of 
stimulation electrodes has been reported in early studies of hardware complications 
(Blomstedt & Hariz, 2005; Hamani & Lozano, 2006). However, with improved surgical 
techniques it has become very uncommon in our own experience. In the first step, test 
stimulation can be helpful to detect a dislocation since either no centrally elicited 
stimulation effects will be observed or the thresholds for stimulation effects and side-effects 
will have changed significantly compared to previous stimulation protocols. As a second 
step, X-ray and computertomography can be used to further evaluate a probable dislocation. 
In case of disconnections of only single contacts of an electrode or short circuits between 
contacts the first step should be to evaluate DBS efficacy after reprogramming. In our 
experience this approach often results in satisfactory symptom control, thereby avoiding 
surgical revision. Moreover, it is of note, that the individual leads for the 4 contacts of a 
quadripolar stimulation electrode cannot be sufficiently visualized radiologically so that in 
case of a disconnection or a short circuit of single contacts X-ray can only demonstrate 
abnormal loops or sharp bends as possible loci minoris resistentiae. 
Battery failure requires immediate impulse generator replacement particularly in patients with 
STN DBS because of the often dramatic increase in PD motor symptoms and the increased 
demand of dopaminergic medication. In fact, sudden battery failure should be avoided by 
regularly checking the remaining battery capacity to anticipate the appropriate time for impulse 
generator replacement. It is noteworthy that a reduction of symptom control after replacement 
of impulse generators can be observed (Allert et al., 2009). The origin of such deterioration can 
be an erroneous change of stimulation parameters or an erroneous connection of the stimulation 
electrodes to the 2 channels of a double channel impulse generator resulting in a change of the 
laterality. However, even if such iatrogenic errors are avoided, some patients may need DBS 
reprogramming for optimal symptom control (Allert et al., 2009).  
In case of a rather slow symptom worsening three possibilities have to be encountered. Firstly, 
DBS efficacy has deteriorated but can be improved by reprogramming (Okun et al., 2005; Moro 
et al., 2006). Secondly, PD medication needs to be adjusted to obtain the full therapeutic 
potential. Thirdly, symptom worsening is due to the natural course of the disease. 
Optimization of stimulation parameters is particularly important during the first months of 
DBS. In many patients a slow reduction of DBS efficacy after the initial programming is 
observed which can be compensated by increasing the stimulation amplitude. In more 
complex clinical situations reprogramming with changes of the active stimulation contacts can 
be helpful. If stimulation parameters have been optimized but symptoms continue to be 
worsened the response to dopaminergic medication needs to be evaluated. Particularly in the 
case of STN DBS dopaminergic medication may have been decreased too much. 
2.5 Counseling of patients and care givers 
The selection of appropriate candidates for DBS surgery is a work-up of the individual risk 
and benefit relationship. It is important to identify those symptoms that will most probably 
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respond to DBS, but also those symptoms that are likely to persist or even take a risk of 
deterioration. Comorbidities have to be evaluated in the same way as psychosocial risk 
factors. Moreover, the patient has to be informed on the mere symptomatic nature of the 
therapy which cannot prevent disease progression (Hilker et al., 2005). 
The success of DBS as perceived by the patient strongly depends on the own expectations 
and it is an important goal of the pre-operative counseling to ensure that these expectations 
are realistic. Apart from the limitations of the prognostic benefit, complications of DBS 
surgery (most notably infection rate and risk of haemorrhage) should be discussed. 
Furthermore, the time course of stabilization should be outlined. Although many patients 
experience significant improvements within a short time after surgery, the stabilization 
period for motor control and side effects can take 3 to 6 months. Particularly after STN DBS 
the possibility of behavioural and psychiatric changes has to be discussed with patients and 
care givers. Hypomania is often rather perceived and complained about by family and 
friends than by the patient. Important decisions on social and financial issues, e. g. divorce, 
selling or buying expensive goods etc. should not be planned shortly after DBS surgery. 
Another issue to be discussed before surgery are limitations to drive a motor vehicle. 
Depending on the country’s legal regulations driving may be restricted for a certain time 
period because of the neurosurgical intervention itself. Apart from that, the ability to drive a 
motor vehicle should be evaluated during the stabilization period after DBS surgery by 
examining both significant motor impairments as well as cognitive/behavioural limitations. 
After surgery patients with DBS and their care givers require counseling on how to behave 
in daily life. Issues of concern are limitations for medical diagnostics and therapies as 
described in 2.6. Furthermore, the risk of interference of DBS with environmental 
electromagnetic waves has to be discussed. The main models of impulse generators in the 
90ies had a magnetic reed switch that could not be switched off. Strong electromagnetic 
waves for example from an electric drill or other sources could result in sudden 
discontinuation of DBS with reoccurrence of motor symptoms. In newer generations of 
impulse generator a magnetic reed switch has been omitted or can be telemetrically disabled 
by the clinician programmer. The risk of interference with environmental electromagnetic 
waves in these impulse generators appears to be very low. 
A handheld patient programmer is an optional device to have limited control of impulse 
generator functions. In our experience many but not all DBS centers provide patients with 
such a patient programmer to enable them on the one hand to make sure that DBS is on in 
case of symptom worsening and on the other hand to allow them checking the impulse 
generator battery. In some patients the patient programmer may even be helpful to further 
adjust and optimize stimulation parameters within predefined limits. In any case, the 
patient and/or patient care giver requires sufficient and often repeated education on the use 
of such a patient programmer. In fact, if the patient programmer is not used in daily life 
there is a significant risk of erroneous use which can for example result in accidentally 
switching off DBS. 
Another area of concern for patients is limitations for physical activities particularly sports. 
Damage of either the stimulation electrode or the extension lead seems feasible if they are 
hit by high energy so that activities with a likelihood of such events should be avoided. Falls 
also seem to bear a risk. However, in our own experience technical damage related to 
physical activity or falls is exceptionally rare although patients may ask for a confirmation 
of normal function after such events. Heat, exposure to sunlight or the use of a sauna do not 
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bear a particular risk for patients with DBS. In summary, physical activities are not 
substantially restricted in patients with DBS. 
2.6 Implications of DBS on medical diagnostics/therapies 
Chronic DBS has implications for several medical diagnostics and therapies. A surface 
electrocardiogram (ECG) can show electrical artefacts particularly in the monopolar 
stimulation mode when the impulse generator serves as the anode (Martin et al., 2003). The 
artefact can be reduced or prevented by either switching off DBS during the ECG or by 
programming a bipolar stimulation mode when both cathode and anode are located 
intracranially (Frysinger et al., 2006). The latter also allows for longer ECG monitoring like 
ambulatory 24 hours Holter ECG. 
Similarly, DBS artefacts can interfere with other electrodiagnostics like 
electroencephalography (EEG), electromyography and evaluation of evoked potentials. If 
DBS cannot be switched off during the examination, a bipolar DBS mode is advised to 
reduce or eliminate these artefacts. The use of transcranial magnetic stimulation (TMS) has 
not been sufficiently investigated. In vitro experiments indicate that TMS can induce 
currents of charge densities that can induce tissue damage so that routine application should 
be avoided (Shimojima et al., 2010; Deng et al., 2010). 
A cardiac pacemaker or defibrillator is not a contraindication for DBS. A major concern is 
that the high frequency stimuli of the impulse generator are sensed by the pacemaker and 
interfere with proper function. Therefore, a bipolar DBS mode is recommended and has 
been found safe in such patients (Capelle et al., 2005). 
X-ray examinations including computertomography (CT) can be safely performed in 
patients with DBS. In contrast, magnetic resonance imaging (MRI) should only be 
performed within important limitations. A full body radiofrequency coil cannot be used 
in patients with DBS because of the risk of electrode heating and tissue damage 
(Henderson et al., 2005). The use of head transmit coils has been found to be safe and 
helpful by many groups (Chhabra et al., 2010; Nazarro et al., 2010, Tagliati et al., 2009) but 
is only recommended according to the manufacturer’s guidelines in experienced centers. 
One study of the effects of 1.5 Tesla MRI in 570 patients did not report any local cutaneous 
nor neurological disorders during or after the MRI. Moreover, no change of the impulse 
generator settings occurred in impulse generators without magnetic reed switch or when 
the magnetic reed switch remained disabled during the procedure (Fraix et al., 2010). 
Diathermy (e.g. shortwave diathermy, microwave diathermy or therapeutic ultrasound 
diathermy) is contraindicated because it can result in tissue damage or damage of parts of 
the neurostimulation system (Nutt et al., 2001). 
3. Conclusion 
DBS has become an important therapeutic option for PD patients. DBS is a symptomatic 
treatment of motor complications requiring not only expertise for the precise implantation 
of stimulation electrodes but also for the post-operative patient management. Optimal 
stimulation parameters are determined by clinical evaluation of short and long-term 
responses. Apart from motor symptoms, stimulation induced non motor symptoms have to 
be observed, most notably psychiatric and behavioural changes. Similarly, medication has to 
be adjusted in response to the DBS motor and non-motor effects. Impedance measurements 
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along with the clinical evaluation of stimulation effects are helpful to evaluate proper 
technical function. Regular follow-up visits are recommended to ensure optimal DBS 
efficacy. Impulse generators should be replaced before complete battery failure to prevent 
sudden recurrence of motor symptoms particularly in the case of STN DBS. DBS systems 
have implications on other medical therapies and diagnostics. Most notably, MRI with full 
body radiofrequency coils and diathermy are contraindicated because of possible tissue 
damage or damage of parts of the DBS system.  
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